How Should Shenyi Capsules Be Used?
Shenyi Capsule is a commonly used adjuvant therapeutic drug for cancer patients, especially during chemotherapy. It can help improve the immune system of the body, enhance physical fitness, and alleviate side effects caused by chemotherapy. Additionally, medical studies have found that it can also enhance the efficacy of treating liver cancer. It is important to follow doctor's instructions and understand the appropriate dosage and usage when using Shenyi Capsule.
Specific issues require specific analysis. If a patient needs to take Shenyi Capsule, they should do so under the guidance of an experienced doctor based on their specific condition. The recommended dosage is two capsules taken orally on an empty stomach before meals, twice a day. Eight weeks constitute one course of treatment.
Pharmacological studies have confirmed that oral administration of Shenyi Capsule, which contains Ginsenoside Rg3, has inhibitory effects on transplanted solid tumors in various animals. When combined with chemotherapy, it can enhance the therapeutic effect on H22 ascites liver cancer in mice, regulate immune function, and prevent decreases in white blood cell count and hair loss. Additionally, it can inhibit the proliferation and growth of tumor vascular endothelial cells and the formation of new blood vessels. The active ingredient of Shenyi Capsule is Ginsenoside Rg3. Domestic scholars have used flow cytometry to study the effects of 20(R)-Ginsenoside Rg3 and found that it can inhibit the proliferation of tumor cells, primarily acting on the G2 phase, effectively suppressing the synthesis of pre-mitotic proteins and ATP, thereby slowing down the proliferation rate of tumor cells.
Shenyi Capsule consists of a single component, Ginsenoside Rg3, which is a trace amount of tetracyclic triterpenoid saponin found in the traditional Chinese medicinal herb Ginseng. Pharmacological studies have demonstrated that oral administration of Ginsenoside Rg3 has inhibitory effects on transplanted solid tumors in various animals. When combined with chemotherapy, it can enhance the therapeutic effect on H22 ascites liver cancer in mice, regulate immune function, and prevent decreases in white blood cell count and hair loss. Additionally, it can inhibit the proliferation and growth of tumor vascular endothelial cells and the formation of new blood vessels.